US Equities Analysis

GEHC — GE HealthCare

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 11.09%
Profit Margins 9.1%
Return on Equity 19.46%
Return on Assets 5.17%
Free Float 0.45B
Dividend Yield 0.21%
Short Int % Utilisation 3.65%

2.2 Growth

Metric Value
Revenue Growth 7.4%
Free Cash Flow 1.48B
EBITDA 10.66 (Ratio)
Enterprise Value 37.55B
EV/Revenue 1.79
EV/EBITDA 10.66

Revenue growth of 7.4% indicates steady, moderate expansion.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 7.07%
Risk / Std Dev (Ann.)* 35.32%
1-Year Price Return* 0.59%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $73.69
52-Week Range $58.75 – $89.77
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

2.5 Valuation & Cash Flow

Valuation basis: The operating-company framework starts with reported EBIT, taxes, non-cash charges, capital expenditure and working-capital movement to derive unlevered free cash flow. It is a current-input research view, not an intrinsic-value target price because a sourced forecast and peer-beta workstream are still required.

Valuation input Value
Last market price $72.37
Market capitalisation $32.69B
Enterprise value proxy $38.66B
Revenue $20.62B
EBIT $3.21B
EBITDA $3.79B
Reported free cash flow $1.50B
Unlevered free cash flow $2.44B
FCF yield 4.60%
EV / EBITDA proxy 10.21x
Net debt / EBITDA 1.58x

WACC Workbench

WACC input Value
Risk-free rate 4.72%
Equity risk premium assumption 5.50%
Beta 0.82
Cost of equity 9.22%
Pre-tax cost of debt 4.44%
WACC 7.82%
WACC validation within standard range

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 4/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and statement data; retrieval timestamp: 2026-08-17 23:38:25.853658 UTC; latest reported fiscal period: 2025-12-31 00:00:00. WACC uses a live 10-year Treasury proxy when available, a 5.50% ERP assumption, reported beta where available, and an interest-expense / average-debt proxy for cost of debt. This is research and analysis only, not personalized financial advice.

us-equity stock equity gehc health-care health-care-equipment nasdaq